1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Vaginitis Global Clinical Trials Review, H2, 2015

Vaginitis Global Clinical Trials Review, H2, 2015

  • December 2015
  • -
  • Global Data
  • -
  • 56 pages

Vaginitis Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Vaginitis Global Clinical Trials Review, H2, 2015" provides an overview of Vaginitis clinical trials scenario. This report provides top line data relating to the clinical trials on Vaginitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Vaginitis Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Figures 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Vaginitis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Vaginitis to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Vaginitis Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 53
Abbreviations 53
Definitions 53
Research Methodology 54
Secondary Research 54
About GlobalData 55
Contact Us 55
Disclaimer 55
Source 56

List of Figures
Vaginitis Therapeutics, Global, Clinical Trials by Region, 2015* 6
Vaginitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vaginitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vaginitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Vaginitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Vaginitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Vaginitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Vaginitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Vaginitis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Vaginitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Vaginitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Vaginitis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Vaginitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Vaginitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Vaginitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Vaginitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Vaginitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Vaginitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Vaginitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Vaginitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Vaginitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Vaginitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Vaginitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

List of Figures
Vaginitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Vaginitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Vaginitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vaginitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Vaginitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Vaginitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Vaginitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Proportion of Vaginitis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Vaginitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Vaginitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Vaginitis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Vaginitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Vaginitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Vaginitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Vaginitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Vaginitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Vaginitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Vaginitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Vaginitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Vaginitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Vaginitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Vaginitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 54

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Proteinuria Treatment Market: By Type (Angiotensin Converting Enzyme (ACE) Inhibitors, Aldosterone Antagonist (i.e., spironolactone), Angiotensin Receptor Blocker (ARB), and Others) & By Region-Forecast (2016-2021)

Proteinuria Treatment Market: By Type (Angiotensin Converting Enzyme (ACE) Inhibitors, Aldosterone Antagonist (i.e., spironolactone), Angiotensin Receptor Blocker (ARB), and Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Proteinuria is a result of an excess of serum proteins in the urine, which can led to renal damage. The most common cause of proteinuria is diabetes. Globally, development the arena of proteomics and ...

Benign prostatic hyperplasia (BPH)- Market Insights, Epidemiology and Market Forecast-2023

Benign prostatic hyperplasia (BPH)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Benign prostatic hyperplasia (BPH) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...

Endometriosis- Market Insights, Epidemiology and Market Forecast-2023

Endometriosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Endometriosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Global Endometriosis Industry

October 2016 $ 4950

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.